1. Park K, Lee J, Lee K, Jung J, Kim SH, Lee J, et al. Epidemiologic linkage of COVID-19 outbreaks at two university-affiliated hospitals in the Seoul Metropolitan Area in March 2020. J Korean Med Sci. 2021; 36(4):e38. PMID:
33496089.
2. Park Y, Huh IS, Lee J, Kang CR, Cho SI, Ham HJ, et al. Application of testing-tracing-treatment strategy in response to the COVID-19 outbreak in Seoul, Korea. J Korean Med Sci. 2020; 35(45):e396. PMID:
33230987.
3. Lim JH, Lee WY, Yun SH, Kim HC, Cho YB, Huh JW, et al. Has the COVID-19 pandemic caused upshifting in colorectal cancer stage? Ann Coloproctol. 2021; 37(4):253–258. PMID:
34376026.
4. Choi JY, Park IJ, Lee HG, Cho E, Kim YI, Kim CW, et al. Impact of the COVID-19 pandemic on surgical treatment patterns for colorectal cancer in a tertiary medical facility in Korea. Cancers (Basel). 2021; 13(9):2221. PMID:
34066390.
5. Manlubatan SI, Lopez MP, Onglao MA, Monroy Iii HJ. Modifications to treatment plan of rectal cancer in response to COVID-19 at the Philippine General Hospital. Ann Coloproctol. 2021; 37(4):225–231. PMID:
34364319.
6. Priou S, Lamé G, Chatellier G, Tournigand C, Kempf E. Effect of the COVID-19 pandemic on colorectal cancer care in France. Lancet Gastroenterol Hepatol. 2021; 6(5):342–343.
7. Morris EJ, Goldacre R, Spata E, Mafham M, Finan PJ, Shelton J, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021; 6(3):199–208. PMID:
33453763.
8. Lee S, Lim AR, Kim MJ, Choi YJ, Kim JW, Park KH, et al. Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea. Eur J Cancer. 2020; 136:69–75. PMID:
32652443.
9. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009; 27(31):5131–5137. PMID:
19738119.
10. Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2014; 97(3):965–971. PMID:
24424014.